Advanced search
1 file | 851.01 KB Add to list

Mitral annular disjunction in heritable thoracic aortic disease : insights from the Montalcino Aortic Consortium

Author
Organization
Project
Abstract
Background: Mitral annular disjunction (MAD), posterior displacement of the mitral valve leaflet hinge point, predisposes to arrhythmias or sudden cardiac death. We evaluated the burden of MAD, mitral valve prolapse (MVP), and mitral regurgitation (MR) by heritable thoracic aortic disease gene in a cross-sectional analysis of 2014-2023 data in the Montalcino Aortic Consortium registry. Methods and Results: MAD was determined by direct measurement of echocardiographic images. MR and MVP were defined according to current clinical guidelines. Associations were evaluated using chi 2 or Fisher exact tests. MR and MVP were enriched in Montalcino Aortic Consortium participants (672) with pathogenic variants (PV) in transforming growth factor-beta pathway genes. The combination of MR and MVP was associated with mitral surgery and arrhythmias. In the subgroup with available images, MAD was enriched in SMAD3 PV compared with other transforming growth factor-beta PV (prevalence ratio 1.8 [1.1-2.8], P <0.02). Severe disjunction (>10 mm) was only observed in the transforming growth factor-beta subgroup and was further enriched in participants with SMAD3 PV (prevalence ratio 3.1 [1.1-8.6]). MVP (prevalence ratio 5.2 [3.0-9.0]) and MR (PR 2.7 [1.8-3.9]) were increased in participants with MAD, but MAD was not independently associated with adverse cardiac or aortic events. Conclusions: Pathological mitral valve phenotypes are more prevalent in individuals with PV in transforming growth factor-beta pathway genes, particularly SMAD3. MR and MVP but not MAD are associated with adverse aortic and cardiac events. Because congenital mitral disease may be the primary presenting feature of SMAD3 PV, genetic testing for heritable thoracic aortic disease should be considered for such individuals, especially if they also have a family history of heritable thoracic aortic disease.
Keywords
cardiovascular genetics, congenital heart disease, Loeys-Dietz syndrome, mitral valve, thoracic aortic aneurysms and dissections, VALVE, ASSOCIATION, SURGERY

Downloads

  • publisher version.pdf
    • full text (Published version)
    • |
    • open access
    • |
    • PDF
    • |
    • 851.01 KB

Citation

Please use this url to cite or link to this publication:

MLA
Asokan, Kishan L., et al. “Mitral Annular Disjunction in Heritable Thoracic Aortic Disease : Insights from the Montalcino Aortic Consortium.” JOURNAL OF THE AMERICAN HEART ASSOCIATION, vol. 13, no. 21, 2024, doi:10.1161/JAHA.124.036274.
APA
Asokan, K. L., Landes, J. R., Renders, W., Muiño Mosquera, L., De Backer, J., Jantzen, D. W., … Montalcino Aortic Consortium, [missing]. (2024). Mitral annular disjunction in heritable thoracic aortic disease : insights from the Montalcino Aortic Consortium. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 13(21). https://doi.org/10.1161/JAHA.124.036274
Chicago author-date
Asokan, Kishan L, Jennifer R Landes, Wannes Renders, Laura Muiño Mosquera, Julie De Backer, David W Jantzen, Anji T Yetman, et al. 2024. “Mitral Annular Disjunction in Heritable Thoracic Aortic Disease : Insights from the Montalcino Aortic Consortium.” JOURNAL OF THE AMERICAN HEART ASSOCIATION 13 (21). https://doi.org/10.1161/JAHA.124.036274.
Chicago author-date (all authors)
Asokan, Kishan L, Jennifer R Landes, Wannes Renders, Laura Muiño Mosquera, Julie De Backer, David W Jantzen, Anji T Yetman, Gisela Teixido-Tura, Arturo Evangelista, Richmond Jeremy, Edward G Jones, Shaine Morris, Tam Doan, Maral Ouzonian, Alan Braverman, Guillaume Jondeau, Olivier Milleron, Dianna M Milewicz, Siddharth K Prakash, Anne De Paepe, Bert Callewaert, Marjolijn Renard, Patrick Sips, and [missing] Montalcino Aortic Consortium. 2024. “Mitral Annular Disjunction in Heritable Thoracic Aortic Disease : Insights from the Montalcino Aortic Consortium.” JOURNAL OF THE AMERICAN HEART ASSOCIATION 13 (21). doi:10.1161/JAHA.124.036274.
Vancouver
1.
Asokan KL, Landes JR, Renders W, Muiño Mosquera L, De Backer J, Jantzen DW, et al. Mitral annular disjunction in heritable thoracic aortic disease : insights from the Montalcino Aortic Consortium. JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2024;13(21).
IEEE
[1]
K. L. Asokan et al., “Mitral annular disjunction in heritable thoracic aortic disease : insights from the Montalcino Aortic Consortium,” JOURNAL OF THE AMERICAN HEART ASSOCIATION, vol. 13, no. 21, 2024.
@article{01JD0T080ASJK7QCBJY65GT66C,
  abstract     = {{Background: Mitral annular disjunction (MAD), posterior displacement of the mitral valve leaflet hinge point, predisposes to arrhythmias or sudden cardiac death. We evaluated the burden of MAD, mitral valve prolapse (MVP), and mitral regurgitation (MR) by heritable thoracic aortic disease gene in a cross-sectional analysis of 2014-2023 data in the Montalcino Aortic Consortium registry. Methods and Results: MAD was determined by direct measurement of echocardiographic images. MR and MVP were defined according to current clinical guidelines. Associations were evaluated using chi 2 or Fisher exact tests. MR and MVP were enriched in Montalcino Aortic Consortium participants (672) with pathogenic variants (PV) in transforming growth factor-beta pathway genes. The combination of MR and MVP was associated with mitral surgery and arrhythmias. In the subgroup with available images, MAD was enriched in SMAD3 PV compared with other transforming growth factor-beta PV (prevalence ratio 1.8 [1.1-2.8], P <0.02). Severe disjunction (>10 mm) was only observed in the transforming growth factor-beta subgroup and was further enriched in participants with SMAD3 PV (prevalence ratio 3.1 [1.1-8.6]). MVP (prevalence ratio 5.2 [3.0-9.0]) and MR (PR 2.7 [1.8-3.9]) were increased in participants with MAD, but MAD was not independently associated with adverse cardiac or aortic events. Conclusions: Pathological mitral valve phenotypes are more prevalent in individuals with PV in transforming growth factor-beta pathway genes, particularly SMAD3. MR and MVP but not MAD are associated with adverse aortic and cardiac events. Because congenital mitral disease may be the primary presenting feature of SMAD3 PV, genetic testing for heritable thoracic aortic disease should be considered for such individuals, especially if they also have a family history of heritable thoracic aortic disease.}},
  articleno    = {{e036274}},
  author       = {{Asokan, Kishan L and Landes, Jennifer R and Renders, Wannes and Muiño Mosquera, Laura and De Backer, Julie and Jantzen, David W and Yetman, Anji T and Teixido-Tura, Gisela and Evangelista, Arturo and Jeremy, Richmond and Jones, Edward G and Morris, Shaine and Doan, Tam and Ouzonian, Maral and Braverman, Alan and Jondeau, Guillaume and Milleron, Olivier and Milewicz, Dianna M and Prakash, Siddharth K and De Paepe, Anne and Callewaert, Bert and Renard, Marjolijn and Sips, Patrick and Montalcino Aortic Consortium, [missing]}},
  issn         = {{2047-9980}},
  journal      = {{JOURNAL OF THE AMERICAN HEART ASSOCIATION}},
  keywords     = {{cardiovascular genetics,congenital heart disease,Loeys-Dietz syndrome,mitral valve,thoracic aortic aneurysms and dissections,VALVE,ASSOCIATION,SURGERY}},
  language     = {{eng}},
  number       = {{21}},
  pages        = {{9}},
  title        = {{Mitral annular disjunction in heritable thoracic aortic disease : insights from the Montalcino Aortic Consortium}},
  url          = {{http://doi.org/10.1161/JAHA.124.036274}},
  volume       = {{13}},
  year         = {{2024}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: